A Little Bird
INDUSTRIES / PHARMA & BIOTECH
Know how your competitors will launch, defend and contract.
Org maps of competitor sales, market access, field medical and marketing teams, by brand and therapeutic area, for commercial and CI leaders at pharmaceutical and biotech companies.
FUNCTIONS WE MAP
01 Field sales
02 Market access
03 Field medical
04 Marketing
Who uses it
Competitive intelligence, commercial strategy, forecasting, market access and medical affairs leaders preparing a launch, defending a franchise, or planning for a loss of exclusivity.
The decisions it informs
Field force size and deployment for a launch, measured against how competitors cover the same prescribers
Account and contracting strategy with payers, PBMs, IDNs and specialty pharmacies
MSL deployment and KOL engagement ahead of a competitor's readout or approval
Forecast assumptions about how hard a competitor will defend share
Response planning when a competitor restructures, reorganizes or cuts a brand team
Why claims and survey data aren't enough
Prescription and claims data show share after it moves. Physician research shows preference and intent. Neither shows how many reps a competitor has on a specialty, how its access team is structured, or whether it is building a medical team before approval. That organization is set months before the data changes.
Questions we answer
How many sales representatives and key account managers support a competing brand, and how are territories drawn?
How is the competitor's market access team organized across national accounts, IDNs and government accounts?
How many MSLs cover the therapeutic area, and which institutions do they prioritize?
Who leads the launch team, and what is its reporting structure?
Is the competitor hiring ahead of a launch, or quietly reducing a mature brand?